Humoral immune response to Covid-19 vaccination in patients with cancer – Results from the ANRS0001S COV-POPART study — Liem Binh Luong Nguyen (2025) | RDL Network
Humoral immune response to Covid-19 vaccination in patients with cancer – Results from the ANRS0001S COV-POPART study
Article 2025 en
Authors
LN
Liem Binh Luong Nguyen
LM
Lyvia Magloire
AF
Alexis François
Abstract
1 min read
Patients with cancer have comparable response rates to controls one month and six months after a booster dose. Our results support the benefit of a booster dose in patients with cancer.
Paul Loubet, L I nda Wittkop, Mathieu Chalouni, David Laplaud, Martine Laville, Bruno Laviolle, Jean‐Daniel Lelièvre, Jean Yves Blay, Benoı̂t Barrou, Benjamin Terrier, Laure Esterle, Stéphanie Nguyen, Axel Levier, Éric Tartour, Xavier de Lamballerie, Odile Launay
Liêm Binh Luong Nguyen, M. Chalouni, P. Loubet, N. Dohollou, O. Tredan, M. Veyri, Z. Maakaroun-Vermesse, I. Ben Ghezala, E. Fourn, D. Merrien, C. Cracowski, A. Barquin, A. Levier, L. Wittkop, O. Launay, Jean Yves Blay, J-P. Spano
Evangelos Terpos, Despina Fotiou, Vangelis Karalis, Ioannis Ntanasis‐Stathopoulos, Aimilia D. Sklirou, Maria Gavriatopoulou, Panagiotis Malandrakis, Vassiliki A. Iconomidou, Efstathios Kastritis, Ioannis P. Trougakos, Meletios A Dimopoulos
Discussion(0)
No comments yet. Be the first to comment.